Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

Epstein-Barr virus-associated carcinoma

MONDO:0017344

Also known as: EBV-associated carcinoma

1637 clinical trials for this condition and its sub-types, 2 tagged with Epstein-Barr virus-associated carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Epstein-Barr virus-related tumor (991)

Sub-types of Epstein-Barr virus-associated carcinoma

Nasopharyngeal carcinoma 210 trials · 211 incl. sub-types
2 sub-types
- Undifferentiated carcinoma of nasopharynx 7 trials
- Carcinoma in situ of nasopharynx 1 trial
Epstein-Barr virus-associated gastric carcinoma 1 trial
Lymphoepithelial-like carcinoma 1 trial

Including sub-types (1637) Tagged with Epstein-Barr virus-associated carcinoma (2)

Not yet finished but already full! 1 Completed 1

New drug targets virus to fight rare cancer

Disease control Ongoing

This phase 2 trial tests a drug called VK-2019 in 13 patients with Epstein-Barr virus (EBV)-positive nasopharyngeal cancer that has returned or spread and has no standard treatment. VK-2019 works by blocking a key viral protein, EBNA1, which the virus needs to survive. The main g…

Phase 2 • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC